12/11/2019  8:08:12 AM Chg. 0.000 Volume Bid8:08:13 AM Ask8:08:13 AM Market Capitalization Dividend Y. P/E Ratio
2.000EUR 0.00% 0
Turnover: 0.000
2.000Bid Size: 100 2.600Ask Size: 1,000 14.37 mill.EUR 0.00% -

Business description

Bio-Gate is a medical technology company that employs unique silver technology to endow materials and products with antimicrobial properties. The focus of the product portfolio is medical technology products. Bio-Gate technology is based on the antimicrobial activity of silver ions. The company employs only pure metallic silver. Bio-Gate uses two different technologies. In the first, silver particles are incorporated into cosmetics, paints, veneers or plastics. The second involves coating final products - such as implants or wound dressings - with a silver-containing functional layer. Both technologies use extremely small particles of silver, to ensure that as many silver ions as possible are released.
 

Management board & Supervisory board

CEO
Marc Lloret-Grau
Management board
Thomas Konradt
Supervisory board
Karl Richter, Volker Rofalski, Prof. Dr. Dr. Volker Alt
 

Company data

Name: Bio-Gate AG
Address: Neumeyerstraße 28-34,D-90411 Nürnberg
Phone: +49-911-4775-23–100
Fax: +49-911-4775-23–101
E-mail: info@bio-gate.de
Internet: www.bio-gate.de/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 8.20%
IPO date: 4/5/2006

Investor relations

Name: Gerd Rückel
IR phone: +49-6172-807-309
IR Fax: -
IR e-mail: presse@bio-gate.de

Main Shareholders

Syntos GmbH
 
52.20%
Mountain Technology AG
 
19.70%
ALTO INVEST SA
 
10.30%
Freefloat
 
8.20%
Richter
 
4.70%
Gründer
 
2.40%
RFH Ltd.
 
2.10%
Fraunhofer Gesellschaft
 
0.40%